• Brain Tumor Surgery

Technology That Is Transforming Brain Surgery

March 3rd, 2022|Comments Off on Technology That Is Transforming Brain Surgery

When Lisa Vidal was diagnosed with a malignant brain tumor, she did something novel among most brain tumor patients. She drank a pink liquid that made her tumor glow, empowering our neurosurgeons to safely remove her tumor with pinpoint accuracy.

  • Optune Device

Tumor Treating Fields Noninvasively Destroy Cancer Cells

March 3rd, 2022|Comments Off on Tumor Treating Fields Noninvasively Destroy Cancer Cells

Tumor treating fields – electric fields that disrupt the electrical charge in the protein that causes cancer cell division – are revolutionizing the treatment of glioblastomas. Neuro-oncologist Nicholas Metrus, MD, describes a new wearable, portable, FDA-approved treatment that creates TTF, interfering with dividing tumor cells and causing them to die.

  • Andrew-M.-Bernstein-DO

Immunotherapy in Action: Changing the Game for Cancer Survival

March 3rd, 2022|Comments Off on Immunotherapy in Action: Changing the Game for Cancer Survival

Years ago, having brain metastases meant a patient would likely have a grim prognosis. Now with immunotherapy and targeted therapy, the game has changed for a number of diseases. Medical oncologist Andrew M. Bernstein, DO, explains.

Zeroing in on Druggable Targets for Metastatic Breast Cancer

March 3rd, 2022|Comments Off on Zeroing in on Druggable Targets for Metastatic Breast Cancer

Breast cancer is the second most common type of cancer to metastasize to the brain. Thankfully, targeted therapies are driving major advances in treatment and improving life expectancy from a number of months to a number of years. Oncologist and director of the Breast Cancer Treatment and Prevention Program at Overlook Medical Center Bonni Lee Guerin, MD, shares the latest.

The Impact of Immuno-Oncology on Melanoma Brain Metastases

December 9th, 2021|Comments Off on The Impact of Immuno-Oncology on Melanoma Brain Metastases

New immuno-oncology drugs have drastically improved survival rates for patients with metastatic melanoma. This includes combination immunotherapy drugs that yield a 50% response rate for patients with melanoma brain metastases, which is why immuno-oncology treatment is typically the best first course of action.

  • cyberknife

Stereotactic Radiosurgery Is on the Rise: Why a Growing Population of Patients with Brain Metastases Are Candidates for CyberKnife®

December 9th, 2021|Comments Off on Stereotactic Radiosurgery Is on the Rise: Why a Growing Population of Patients with Brain Metastases Are Candidates for CyberKnife®

CyberKnife has completely changed the way metastatic brain tumors are treated by administering radiation only where it’s needed – and not where it’s not. Not only is CyberKnife a highly effective therapy for the treatment of brain metastases, its precision spares healthy brain tissue from radiation exposure and the neurocognitive damage it can cause.

  • Metastatic Brain Cancer

Beating Metastatic Brain Cancer with Surgery and CyberKnife

December 9th, 2021|Comments Off on Beating Metastatic Brain Cancer with Surgery and CyberKnife

“You are disease-free in the brain.” Hearing these words nearly a year after discovering kidney cancer had spread to his brain brought 56-year-old Edward Battaglia to tears. This triumph was his latest victory in a cancer journey that spans more than a decade.

LET’S WORK TOGETHER

We work as a single united team with market leading firms around the world and give our clients the highest quality advice possible.